Biblio Discovery — Demo Discovery Service

20 results for "Anthony Hauser"

Showing 1–20 · 0.52 seconds · RSS

  1. Journal Article

    Direct and indirect effects of the COVID-19 pandemic on mortality in Switzerland

    Julien Riou; Anthony Hauser; Anna Fesser et al.

    Nature Communications, Vol. 14 No. 1 · 2023 · English · DOAJ Scopus

    COVID-19-releated public health measures may have indirectly impacted mortality rates by causing or averting deaths. Here, the authors use data from Switzerland until April 2022 and estimate that, after accounting for deaths directly related to COVID-19, mortality was lower than expected…

  2. Journal Article

    COVID-19 disrupted patterns of cause-specific mortality in Switzerland

    Anthony Hauser; Moritz Wagner; Anna Fesser et al.

    International Journal of Public Health, Vol. 71 · 2026 · English · DOAJ Scopus

    ObjectivesTo understand disruptions in mortality patterns during the COVID-19 pandemic beyond deaths directly attributed to SARS-CoV-2.MethodsWe analysed Swiss weekly deaths (2011–2021) by age, sex, region, and nine cause groups. For each age group, a Bayesian multivariate Poisson model was fitted…

  3. Journal Article

    HIV drug resistance in sub-Saharan Africa: public health questions and the potential role of real-world data and mathematical modelling

    Reneé de Waal; Richard Lessells; Anthony Hauser et al.

    Journal of Virus Eradication, Vol. 4 · 2018 · English · DOAJ Scopus

    The prevalence of pretreatment resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) is >10% in many low-income countries. As a consequence, several sub-Saharan African countries have implemented, or are considering the introduction of, non-NNRTI-based first-line antiretroviral…

  4. Journal Article

    Socio-demographic characteristics associated with COVID-19 vaccination uptake in Switzerland: longitudinal analysis of the CoMix study

    Martina L Reichmuth; Leonie Heron; Julien Riou et al.

    BMC Public Health, Vol. 23 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Background Vaccination is an effective strategy to reduce morbidity and mortality from coronavirus disease 2019 (COVID-19). However, the uptake of COVID-19 vaccination has varied across and within countries. Switzerland has had lower levels of COVID-19 vaccination uptake in the general…

  5. Journal Article Full text

    Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe

    Anthony Hauser; Michel J. Counotte; Charles C. Margossian et al.

    PLOS Medicine, Vol. 17 No. 7 · 2020 · English · PLOS Scopus

    Background: As of 16 May 2020, more than 4.5 million cases and more than 300,000 deaths from disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported. Reliable estimates of mortality from SARS-CoV-2 infection are essential for understanding clinical…

    Also available at: DOAJ

  6. Journal Article Full text

    Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa

    Anthony Hauser; Katharina Kusejko; Leigh F. Johnson et al.

    PLOS Computational Biology, Vol. 15 No. 6 · 2019 · English · PLOS Scopus

    The scale-up of antiretroviral therapy (ART) in South Africa substantially reduced AIDS-related deaths and new HIV infections. However, its success is threatened by the emergence of resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTI). The MARISA (Modelling Antiretroviral drug…

    Also available at: DOAJ

  7. Journal Article Full text

    Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study

    Anthony Hauser; Katharina Kusejko; Leigh F. Johnson et al.

    PLOS Medicine, Vol. 17 No. 12 · 2020 · English · PLOS Scopus

    …age, would only slow down the increase in levels of NNRTI PDR. Anthony Hauser and co-workers model the implications of dolutegravir scale-up for drug resistance in antiretroviral treatment in South Africa. Why was this study done?: What did the researchers do and find?: What do these findings mean?:

    Also available at: DOAJ

  8. Journal Article Full text

    Assessing the potential impact of transmission during prolonged viral shedding on the effect of lockdown relaxation on COVID-19

    Burcu Tepekule; Anthony Hauser; Viacheslav N. Kachalov et al.

    PLOS Computational Biology, Vol. 17 No. 1 · 2021 · English · PLOS Scopus

    A key parameter in epidemiological modeling which characterizes the spread of an infectious disease is the generation time, or more generally the distribution of infectiousness as a function of time since infection. There is increasing evidence supporting a prolonged viral shedding window for…

    Also available at: DOAJ

  9. Journal Article

    Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: an observational study from routine surveillance data in Switzerland

    Nanina Anderegg; Christian L. Althaus; Samuel Colin et al.

    Swiss Medical Weekly, Vol. 152 No. 1516 · 2022 · English · DOAJ Scopus

    BACKGROUND: In Switzerland, SARS-CoV-2 vaccination campaigns started in early 2021. Vaccine coverage reached 65% of the population in December 2021, mostly with mRNA vaccines from Moderna and Pfizer-BioNtech. Simultaneously, the proportion of vaccinated among COVID-19-related hospitalisations and…

  10. Journal Article Full text

    Bayesian workflow for time-varying transmission in stratified compartmental infectious disease transmission models

    Judith A. Bouman; Anthony Hauser; Simon L. Grimm et al.

    PLOS Computational Biology, Vol. 20 No. 4 · 2024 · English · PLOS Scopus

    Compartmental models that describe infectious disease transmission across subpopulations are central for assessing the impact of non-pharmaceutical interventions, behavioral changes and seasonal effects on the spread of respiratory infections. We present a Bayesian workflow for such models…

    Also available at: DOAJ

  11. Journal Article Full text

    Identifying the drivers of multidrug-resistant Klebsiella pneumoniae at a European level

    Viacheslav N. Kachalov; Huyen Nguyen; Suraj Balakrishna et al.

    PLOS Computational Biology, Vol. 17 No. 1 · 2021 · English · PLOS Scopus

    Beta-lactam- and in particular carbapenem-resistant Enterobacteriaceae represent a major public health threat. Despite strong variation of resistance across geographical settings, there is limited understanding of the underlying drivers. To assess these drivers, we developed a transmission model of…

    Also available at: DOAJ

  12. Journal Article Full text

    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis

    Diana Buitrago-Garcia; Aziz Mert Ipekci; Leonie Heron et al.

    PLOS Medicine, Vol. 19 No. 5 · 2022 · English · PLOS Scopus

    Background: Debate about the level of asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection continues. The amount of evidence is increasing and study designs have changed over time. We updated a living systematic review to address 3 questions: (1) Among people who…

    Also available at: DOAJ

  13. Journal Article

    Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response

    Maddalena Marconato; Irene A. Abela; Anthony Hauser et al.

    The Journal of Clinical Investigation, Vol. 132 No. 12 · 2022 · English · DOAJ Scopus

    BACKGROUND Neutralizing antibodies are considered a key correlate of protection by current SARS-CoV-2 vaccines. The manner in which human infections respond to therapeutic SARS-CoV-2 antibodies, including convalescent plasma therapy, remains to be fully elucidated.METHODS We conducted a…